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Objective: To evaluate the results of the expanded National Venous Screening Program (NVSP) as administered by the
American Venous Forum.
Methods: Eighty-three physicians across 40 states participated in screening Americans for venous disease. The NVSP
instrument included demographics, venous thromboembolism (VTE) risk assessment, quality-of-life (QOL) assessment,
duplex ultrasound scan for reflux and obstruction, and clinical inspection. Participants received educational materials and
a report card to give their physician.
Results: A total of 2234 individuals underwent screening (mean, 26 people/site; range, 4-42). Demographic data
observed included mean age of 60 years (range, 17-93 years); 77% female; 80% Caucasian; mean BMI of 29 (range,
11-68); 40% current or previous smoker; and 24% taking antiplatelet therapy and 4% taking warfarin. If placed in a
situation conducive for VTE, 40% of participants were low risk, 22% were moderate risk, 21% were high risk, and 17%
were very high risk. On a venous QOL assessment, 17% had a combined total score for all 11 questions of “very limited”
or “impossible to do.” Reflux or obstruction was noted in 37% and 5% of participants, respectively. CEAP class 0 to 6 was
29%, 29%, 23%, 10%, 9%, 1.5%, 0.5%, respectively.
Discussion: Despite a dramatic expansion in the second annual NSVP (from 17 to 83 centers), the presence of venous
disease observed in a larger screened population continues to be high. The NVSP represents one pathway to increasing
public awareness about venous disease. ( J Vasc Surg 2008;48:394-9.)The sequelae of venous thromboembolism (VTE) and
chronic venous disease (CVD) continue to cause major
mortality and significant morbidity in millions of Ameri-
cans. Despite a considerable wealth of knowledge that has
been acquired over the past 25 years about the basic sci-
ence, natural history, risk factor delineation, prevention,
and treatments of these two common manifestations of
venous disease, a significant proportion of physicians, allied
health personnel, health care administrators, and, most
importantly, the lay public continue to be conspicuously
unaware of these advances.1-4 Bridging this gap by involv-
ing the aforementioned groups in screening of Americans
for venous disease represents a major goal of the American
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394Venous Forum (AVF) to increase awareness of venous
disease.
Findings from the pilot launch of the National Venous
Screening Program (NVSP) during 2005 and 2006, which
involved 17 centers, were profound.5 Important observa-
tions included 77% of participants were at high or very high
risk of developing VTE if put in a high-risk situation; 40%
and 6% had evidence of venous reflux or obstruction,
respectively; and, according to the CEAP criteria,6 20% had
a clinical classification of 3 or greater. Additionally, the
screening instrument demonstrated correlation between
risk stratification, duplex ultrasound findings, and severity
of CVD by inspection. Data and analysis presented herein
reflect the findings of a broad expansion of the NVSP 1 year
after the pilot program.
METHODS
Oversight for the expansion of the NVSP was provided
by the NVSP committee of the AVF (co-chairs, R.M.,
M.P.). Michele F. Lentz (NVSP Coordinator, RF Associ-
ates, Baltimore, Md) in concert with Administrare, Inc
(Salem, Mass) assisted in executing the expansion as pre-
scribed by the NVSP Committee.
Physicians targeted for participation in the NVSP were
members of one of three medical societies: the American
Venous Forum, the Society for Vascular Surgery, and the
American College of Phlebology. Membership mailing lists
were given to the NVSP committee for the sole purpose of
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participate and “save the dates” were distributed by elec-
tronic mail in August 2006. National Venous Screening
Week was designated from November 6-11, 2006. Physi-
cians desiring to participate in the NVSP were not limited
to only that time; they could perform a screening during
the following 4 months. Instructional and educational ma-
terials needed to perform the NVSP were provided to
physicians and the public for free. Funding for the NVSP
was through grants from Juzo Corporation (Cleveland,
Ohio) and Sanofi-Aventis (Bridgewater, NJ). Materials
given to physicians and the public had no associated indus-
try labeling or advertising.
The process of the NVSP screening has been previously
described in detail.5 Briefly, participants who attended a
free screening completed a self-administered demographic
questionnaire and VTE risk assessment, underwent an ab-
breviated duplex ultrasound examination for venous reflux
and obstruction, and had their lower extremities inspected
and graded according to CEAP classification.6 Briefly, the
abbreviated duplex ultrasound testing examined the com-
mon femoral vein, saphenofemoral junction, and the
above-knee popliteal vein. Participants were put in the
supine position with the head of the bed elevated to 30
degrees; then a Valsalva maneuver was performed at each
vein location to evaluate for reversal of flow greater than 0.5
seconds. Manual compression of the same segments using
B-mode was performed to evaluate for obstruction. Ob-
struction was defined as the inability to completely oppose
the walls because of an acute or chronic deep venous
thrombosis (DVT).
In a new feature of the expanded NVSP, participants
also completed an abbreviated form of the previously vali-
dated Chronic Venous Insufficiency Quality of Life ques-
tionnaire (CIVIQ).7,8 The abbreviated CIVIQ question-
naire ranked symptoms experienced during the last 4 weeks
before the screening according to a Likert scale of 1 to 5
(1  no pain/not bothered at all; 5  intense pain/
impossible to do). Of the 11 questions used, four addressed
pain repercussions, four addressed physical functioning,
and three addressed social activities.
After completion of the aforementioned steps, an exit
interview was completed by the physician who then dis-
cussed with the participant the screening findings. Partici-
pants received a venous report card and were encouraged to
share the report with their primary care physician. Partici-
pants also received free educational brochures on common
venous afflictions as well as a monograph explaining the
meaning of their VTE risk assessment if they were placed in
a high-risk situation.
Data from each screening site were sent to Michele F.
Lentz who coordinated entry into the NSVP database
(Access; Microsoft Corp, Seattle, Wash). Statistical analyses
were performed with SAS v9.1 (SAS Institute Inc, Cary,
NC) with the assistance of the Division of Statistics and
Research Consulting at Southern Illinois University
(S.M.). Relationships between participant demographics,
VTE risk factors, presence/absence of venous reflux andobstruction, CEAP classification, and CIVIQ quality-of-
life scores were examined. Independent group t tests
were used to compare the presence/absence of reflux or
obstruction with variables that included age, body mass
index (BMI), and VTE risk score. The relationship of the
presence/absence of reflux or obstruction to categorical
demographic variables was examined with 2 tests of
independence. These tests were also used to examine the
relationship of VTE risk category with similar variables.
Wilcoxon rank sum tests were performed to compare di-
chotomous CEAP classification on demographic, VTE risk,
reflux/obstruction, and CIVIQ variables. Spearman corre-
lation coefficients were used to examine the relationships
between CIVIQ variables and VTE risk score and CEAP
classification. For purposes of comparison, current and past
smokers were grouped together as smokers. In compari-
sons between VTE risk groups, low and moderate risk were
combined as was high and very high risk. Multivariate
analysis was not performed because of low numbers of
significant findings in the univariate analyses for each major
group comparison. P values less than .05 were considered
statistically significant.
RESULTS
After distribution of invitations to participate to mem-
bers of the three aforementioned societies, 164 physicians
indicated a desire to participate and received materials to
conduct the NVSP. Eighty-three (51%) physicians com-
pleted a screening and returned data for entry into the
database (Fig 1). To ensure maximum return of data, the
NVSP coordinator oversaw follow-up with participating
physicians who received materials. A total of 2234 individ-
uals were screened in 40 states with a mean of 26 partici-
pants screened per site (range, 4-42). General demograph-
ics for the entire population screened are listed in Table I.
Most participants (82%) indicated their primary physician
was either in family practice (48%) or internal medicine
(34%). Reasons cited for attending the screening included
60% desiring a free screening, 42% having varicose veins,
35% having leg pain, 18% having a swollen leg, 7% having a
“blood clot”, and 6% having a cosmetic problem.
Table II outlines the each participant’s answers to the
questions about risk factors for VTE. Fig 2 illustrates the
distribution of the total point score across the population
screened. On the basis of affirmative answers and cumula-
tive score,5,6 VTE risk assessment for participants if they
were placed in a high-risk situation was as follows: 17% of
people screened were at very high risk (5 points); 21%
were at high risk (3-4 points); 22% were at moderate risk (2
points); and 40% were at low risk (0-1 point). Table III
shows the distribution of reflux and obstruction discovered
in the common femoral vein, saphenofemoral vein junc-
tion, and popliteal vein for each leg for the entire group.
Thirty-seven percent of participants had one or more seg-
ments of reflux, and 5% had one or more segments of
obstruction. Table IV lists the distribution of clinical class
(CEAP) for CVD. Varicose veins were present in 23% of
people, edema without skin changes in 10%, skin changes
Warfarin 89 (4)
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venous stasis ulcer in 2.0%. Table V shows the results of
distribution of answers for the abbreviated CIVIQ ques-
tionnaire. In the four questions addressing pain, 29% of
participants had a score 3 (moderately to intensely both-
ered or limited). Similarly, a score 3 for the four physical
functioning questions and the three social activity ques-
tions was observed in 25% and 20%, respectively.
Age of participants with reflux (mean, 59 years; SD 
12.9 years) compared with those without reflux (mean, 60
years; SD  12.9 years) reached a statistically significant
difference (P  .01). The VTE risk score in those with
reflux (mean, 2.0; SD  2.0) was significantly higher (P 
.0001) than in those without reflux (mean, 1.4; SD 1.9).
Age of participants with obstruction (mean, 63 years; SD
13.9 years) compared with those without obstruction
(mean, 60 years; SD  13.0 years) reached a statistically
significant difference (P  .02). The VTE risk score in
those with obstruction (mean, 2.4; SD  2.2) was signifi-
cantly higher (P  .0001) than in those without obstruc-
tion (mean, 1.6; SD  2.0). Caucasians had significantly
less obstruction compared with non-Caucasians (4% vs 9%;
P  .001). Participants with diabetes mellitus had signifi-
cantly more obstruction than participants without obstruc-
each site (n  83) for the National Venous ScreeningTable I. General demographics and medical information
for 2234 individuals participating in the National Venous
Screening Program
Variable Mean; median (range)
Age (y) 60; 62 (17-93)
Body mass index 29; 25 (11-68)
Number (percent)
Gender
Female 1720 (77)
Male 514 (23)
Race
Caucasian 1787 (80)
African American 134 (6)
Hispanic 67 (3)
Asian 67 (3)
Pre-existing conditions
Diabetes mellitus 223 (10)
Hypertension 760 (34)
Congestive heart failure 45 (2)
Smoking status
Non-smoker 1340 (60)
Smoker 156 (7)
Past smoker 737 (33)
Current treatment
Aspirin 491 (22)
Clopidogrel 45 (2)Fig 1. Map of the United States showing the location of the
Program.tion (9% vs 4.5%; P .005). Participants with hypertension
ssigne
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hypertension (7.5% vs 3.7%; P  .0001). Participants with
obstruction were significantly more likely to be taking
warfarin compared with those without obstruction (12% vs
4.6%; P .001). The BMI did not differ in those with and
without reflux (P .26) or obstruction (P .06). Smoking
status did not differ in those with and without reflux (P 
.09) or obstruction (P  .58).
Significantly higher CEAP classification scores were
observed in participants with reflux (P  .001) or hyper-
tension (P  .01) and in participants having a VTE risk in
the combined high/very high categories (P  .001). In-
creasing CIVIQ scores (decreasing QOL) also correlated
with higher CEAP classification (r  0.08; P  .01).
Table II. Number (percent) of people (n  2234) who g
venous thromboembolism if placed in a high-risk situation
1. Have you ever had a blood clot in your legs or lungs?
2. Do you have a family history of blood clots in the veins?
3. Do you currently or have you ever had swollen legs?
4. Do you have visible varicose veins other than spider veins?
5. Do you have ileitis, Crohn disease, or inflammatory bowel dis
6. Do you have serious lung disease or emphysema?
7. Within the last month, have you had more that 3 days of cont
8. Within the last month, have you had a pelvic fracture or a plas
9. Have you had a stroke, heart attack, or heart failure?
10. Have you had major surgery lasting over an hour in the last m
11. Do you have or have you had a malignant disease (cancer)?
12. Do you weigh over 250 pounds?
13. Age between 40-59 years?
14. Age between 60-69 years?
15. Age equal to or greater than 70 years?
Women only
16. Do you take birth control pills or estrogen (hormone) replace
17. Are you pregnant or have you given birth within the last mon
Number in parentheses after each question represents the number of points a
Fig 2. The bar graph depicts the distribution across the screened
population (n 2234) of the total number of points (indicative of
increasing number of risk factors) for developing venous throm-
boembolism if placed in a high-risk situation.Further analyses revealed that CIVIQ scores were signifi-cantly higher (decreasing QOL) in participants with the
following variables: African American (P  .006); female
(P  .001); smoking (P  .006); heart failure (P  .007);
hypertension (P  .001); diabetes mellitus (P  .0003);
VTE risk in high/very high category (P  .001).
DISCUSSION
Expansion of the NVSP in the United States has led to
further knowledge of the risk and presence of venous
disease in a screened population. Although the screening is
not a randomized sample of the public, valuable informa-
tion has been acquired about the population who re-
sponded to the offer of a free screening. Demographics of
those individuals across 40 US states were similar to those
of the smaller NVSP pilot in 17 centers performed 1 year
earlier.5 The population reported herein was largely older
(mean age, 60 years), Caucasian (80%), female (77%), and
obese (mean BMI, 29).
Several inferences can be made regarding these data.
First, older Americans are more prone to venous disease,
which may increase their interest in obtaining more infor-
mation. Additionally, retired Americans may have a sched-
ule conducive to participating in screenings. Information is
lacking as to the demographics of minorities who lived in
the vicinity of each site and participated in the NVSP. This
important and complex issue requires efforts by the AVF to
increase the opportunities for screening in minorities. Nev-
ertheless, expansion of the NVSP did show significantly
more obstruction in minorities (as a whole) than in Cauca-
sians (9% vs 4%; P .001) as determined by an abbreviated
duplex ultrasound examination. African Americans were
also observed to have significantly worse CIVIQ QOL
scores. The predominance of women desiring to participate
could be due to the higher incidence of varicose veins in this
ffirmative answers to questions that assess their risk for
Number (percent)
(3) 168 (8)
(3) 292 (13)
(1) 438 (20)
(1) 1146 (51)
(1) 105 (5)
(1) 59 (3)
s bed rest attributable to injury or illness? (1) 48 (2)
g cast? (1) 12 (1)
(1) 105 (5)
? (1) 17 (1)
(2) 157 (7)
(1) 110 (5)
(1) 631 (28)
(2) 368 (16)
(3) 399 (18)
therapy? (1) 164 (7)
(1) 3 (0.1)
d if an affirmative answer is given. Points are added to calculate the risk score.ave a
ease?
inuou
ter le
onth
ment
th?population as well as their increased attention to use of
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attracting men, particularly with regard to education about
the risk of VTE and more severe forms of CVD. Obesity
continues to plague Americans as exemplified in those
individuals participating in the NVSP. Indeed, even with a
dramatic expansion in the number of participants compared
with the previous year (476 vs 2234 individuals), the mean
screening BMI increased by one point to 29, which is still in
the overweight category but borders on the obese category
(BMI  30).
Risk factor delineation, abbreviated duplex ultrasound
examination, and classification of CVD showed similarities
to findings in the smaller pilot NVSP report (Tables II-IV).
These data underscore the importance of increasing efforts
to provide more education about venous disease in the
public arena. Important to the next phase of the NVSP is to
determine what course individuals follow after obtaining
information from the screening and, more importantly, if
they retain information about identification and risk of the
disease process. Do those screened individuals actually give
the report card to their physician? Do participants seek
further information and find potential treatments?Will they
alert their physician as to their risk of DVT if put in a
high-risk situation? The AVF will seek to answer these
important questions, because this screened population was
the first to sign a release form allowing NVSP representa-
tives to contact them at a later date for further follow-up.
Statistical analyses continue to illustrate the strength of
the NVSP as a valid process. Significantly higher CEAP
classification scores were observed in participants with re-
flux and those having a VTE risk in the combined high/
very high categories. Moreover, VTE risk scores were sig-
nificantly higher in those individuals with reflux or
obstruction. Interestingly, varying BMI and smoking did
not show any differences with regard to the presence of
Table III. Percent of vein segments that were positive by
valve reflux or obstruction in each lower extremity of the p
Reflux right leg R
Common femoral vein 15%
Saphenofemoral vein junction 21%
Popliteal vein 8%
Table IV. Percent distribution of participants (n 
2234) with the highest CEAP classification for chronic
venous disease (CVD)
Classification Distribution
C0 (no CVD) 29%
C1 (telangiectasias) 29%
C2 (varicose veins) 23%
C3 (edema) 10%
C4 (skin changes) 7%
C5 (healed ulcer) 1.5%
C6 (ulcer) 0.5%venous reflux or obstruction.Added to the expansion of NVSP was the administra-
tion of an abbreviated form of the CIVIQ. Because of the
need for brevity in the screening process, questions in the
full questionnaire pertinent to the effect on morale (ques-
tions 12-20) were not used. The first 11 questions of the
full CIVIQ are more specific for vein symptoms that affect
the legs and were deemed more appropriate for use in the
screening process. These data also illustrate increasing
CIVIQ scores (decreasing QOL) in participants with
ex ultrasound examination for the presence of venous
ation screened (n  2234)
left leg Obstruction right leg Obstruction left leg
% 3% 3%
% 3% 3%
% 4% 4%
Table V. Percent distribution (in bold) of findings for
participants who completed the abbreviated Chronic
Venous Insufficiency Quality of Life questionnaire
(CIVIQ)
1. What is the intensity of the pain?
None Light Moderate Strong Intense
1 (23) 2 (29) 3 (29) 4 (14) 5 (5)
2. Bothered/limited in your work or other daily activities?
None A little Moderately Very Extremely
1 (36) 2 (31) 3 (21) 4 (9) 5 (3)
3. How often do you sleep badly?
Never Seldom Fairly Very Every night
1 (34) 2 (32) 3 (20) 4 (10) 5 (4)
4. Bothered/limited by standing for a long time?
None A little Moderately Very Extremely
1 (25) 2 (32) 3 (23) 4 (18) 5 (2)
5. Bothered/limited by climbing stairs?
None A little Moderately Very Extremely
1 (36) 2 (29) 3 (18) 4 (15) 5 (2)
6. Bothered/limited by crouching/kneeling?
None A little Moderately Very Extremely
1 (31) 2 (26) 3 (18) 4 (17) 5 (8)
7. Bothered/limited by walking briskly?
None A little Moderately Very Extremely
1 (40) 2 (28) 3 (16) 4 (11) 5 (5)
8. Bothered/limited by travel by car, bus, plane?
None A little Moderately Very Extremely
1 (39) 2 (31) 3 (20) 4 (9) 5 (1)
9. Bothered/limited in performing housework such as working
in kitchen, carrying child, cleaning floors, doing handy work?
None A little Moderately Very Extremely
1 (40) 2 (29) 3 (19) 4 (10) 5 (2)
10. Bothered/limited in going to discos, weddings, parties,
cocktails?
None A little Moderately Very Extremely
1 (61) 2 (20) 3 (9) 4 (6) 5 (4)
11. Bothered/limited in strenuous sporting activities?
None A little Moderately Very Extremely
1 (44) 2 (24) 3 (13) 4 (9) 5 (10)
Symptoms/activities asked about in the questionnaire pertained to or were
caused by the ankles/legs during the last 4 weeks prior to the screening. (For
purposes of reporting, the questions and answers are shortened versions of
those in the original CIVIQ.)dupl
opul
eflux
16
21higher CEAP classification and in those with VTE risk in
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validation of the CIVIQ used 20 questions,7,8 the abbrevi-
ated version also shows correlation with individuals with
increasing severity of CVD and those at increasing risk of
developing acute VTE if put in a high-risk situation. Of
note, the finding that African Americans were significantly
more likely to have a higher CIVIQ score (lower QOLwith
respect to venous disease) should be viewed in the context
that this specific QOL questionnaire was not previously
validated in this ethnic group.
The pilot NVSP performed a year earlier provided
valuable guidance to appropriately expand the program.
One important step to improvement was providing more
educational information to the participants about the VTE
risk assessment and the meaning of being placed in a
high-risk situation conducive to increasing the risk of VTE.
A specificmonograph developed tomore fully explain these
concepts in lay terms was given to participants. This mono-
graph further assisted physicians in assuring participants
that, although their VTE risk may be very high if placed in
a high-risk situation such as undergoing major abdominal
surgery, the risk at the time of the screening would be
considerably lower given that they are not in that high-risk
situation. The AVF will continue its mission to educate,
identify, and empower Americans about and with all types
of venous disease, acute and chronic. Certainly the scope
and presence of venous disease necessitate continued action
in the public and health professional sectors. More work is
needed, particularly in the area of physician awareness
about proper DVT prophylaxis and new opportunities for
treatment. New opportunities assimilated from this expan-
sion include the possible addition of the venous clinical
severity score as well as looking for opportunities to work
with hospital systems to foster more screening and physi-
cian education. As with education about other important
preventive health measures, such as the use of seat belts or
the ill effects of smoking, we should also provide education
about how to prevent the devastating effects of venous
disease. This enormous socioeconomic burden deserves
more attention.AUTHOR CONTRIBUTIONS
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